Soite will begin offer­ing a third vac­cine dose to all per­sons old­er than 18 after 5–6 months have passed since their sec­ond dose

In accor­dance with the Finnish Insti­tute of Health and Welfare’s rec­om­men­da­tions, today on Fri­day Decem­ber 3rd, Soite will begin offer­ing a third coro­n­avirus vac­cine dose to every­one aged 18 and old­er after 5–6 months have passed since their sec­ond dose.

This means that about 21,000 res­i­dents in the Soite area cur­rent­ly have the right to a third dose. This may cause con­ges­tion at the vac­ci­na­tion sites, espe­cial­ly before noon. We rec­om­mend that those who come to get vac­ci­nat­ed try to spread out through­out the day in order to avoid congestion.

Coro­n­avirus vac­ci­na­tions are now main­ly done dur­ing appoint­ment-free walk-in vac­ci­na­tion days. On vac­ci­na­tion days with­out appoint­ment book­ing, you can come to get your coro­n­avirus vac­ci­na­tion when it suits you best. Addi­tion­al infor­ma­tion and the timetable for the walk-in days can be found on Soite’s coro­n­avirus web­site:

An appoint­ment for a coro­n­avirus vac­ci­na­tion may still be booked online on or by phone on the num­ber 06 828 7488. Phone hours Mon­day to Thurs­day from 9 am to 3 pm and Fri­day 9 am to 2 pm. You can also book an appoint­ment via your health cen­tral (page is in Finnish)

For groups that the Finnish Insti­tute of Health and Wel­fare has already rec­om­mend­ed a third vac­cine dose for, a boost­er vac­cine dose is also rec­om­mend­ed 5 to 6 months after the sec­ond dose. These groups include, for exam­ple, per­sons aged 60 or old­er, those vac­ci­nat­ed with a short dose inter­val, social and health care per­son­nel treat­ing coro­n­avirus patients and social and health care per­son­nel pro­vid­ing oth­er urgent care, as well as per­son­nel work­ing with­in the around the clock care ser­vices. For heav­i­ly immuno­com­pro­mised per­sons, a third dose is rec­om­mend­ed 2 months after the sec­ond dose, just as before.

Pre­vi­ous­ly, it was rec­om­mend­ed that for per­sons oth­er than those who are immuno­com­pro­mised, a third dose should not be giv­en until six months after the sec­ond dose. The boost­er vac­cine could now be giv­en a lit­tle soon­er. The rec­om­men­da­tion regard­ing a third dose also applies to men younger than 30, whose third dose will be giv­en using the BioN­Tech-Pfiz­er Comir­naty vaccine.

The most impor­tant thing to do in order to pre­vent coro­n­avirus infec­tions and seri­ous cas­es of coro­n­avirus dis­ease is still to take the first two coro­n­avirus vac­cine doses.

The inter­val between the first and sec­ond dose affects how effec­tive­ly the vac­cine pro­tects you. A longer dose inter­val leads to bet­ter lev­els of anti­bod­ies, and they also remain at a high­er lev­el for a longer time.

The Insti­tute has instruct­ed that the third dose should be giv­en using pri­mar­i­ly the same vac­cine prod­uct that was used for the sec­ond dose. How­ev­er, in order to ensure that there is enough vac­cines, it will be nec­es­sary to make a change so that some of those who were giv­en their sec­ond dose using Pfizer’s Comir­naty vac­cine will receive their third dose using Moderna’s Spike­vax vaccine.

In stud­ies, the effect of Spike­vax has been shown to be at least equal to that of Comir­naty. Some stud­ies have even shown Spike­vax to be more effec­tive than Comirnaty.

Based on expe­ri­ence from around the world, cross-use of Comir­naty and Spike­vax vac­cines has been safe and the vac­cine pro­tec­tion has been at least as good as that of those who have received vac­cine dos­es using only one vac­cine prod­uct. No unex­pect­ed seri­ous adverse reac­tions have been observed when the vac­ci­na­tion series has been con­tin­ued with anoth­er product.


Social Media